CHA Biotech Co. Ltd Long-term Investment Intensity
CHA Biotech Co. Ltd long-term investment intensity. CHA Biotech Co. Ltd (085660) has a Long-term Investment Intensity of 10.6% as of September 2019. Long-term investments of ₩122.58 Billion represent 10.6% of total assets of ₩1.16 Trillion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See CHA Biotech Co. Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of CHA Biotech Co. Ltd (2014–2018)
Long-term investment intensity of CHA Biotech Co. Ltd from 2014 to 2018. This chart shows how CHA Biotech Co. Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2018. As of September 2019, the intensity stands at 10.6%, reflecting long-term investments of ₩122.58 Billion against total assets of ₩1.16 Trillion KRW. See 085660 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
CHA Biotech Co. Ltd Long-term Investment Intensity by Year (2014–2018)
CHA Biotech Co. Ltd long-term investment intensity by year from 2014 to 2018. The table below presents the year-by-year Long-term Investment Intensity for CHA Biotech Co. Ltd from 2014 to 2018, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of CHA Biotech Co. Ltd.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 6.3% | ₩59.53 Billion | ₩947.53 Billion | ▲ +0.9 pp |
| 2017 | 5.3% | ₩42.35 Billion | ₩793.61 Billion | ▲ +3.0 pp |
| 2016 | 2.4% | ₩18.08 Billion | ₩768.93 Billion | ▲ +0.8 pp |
| 2015 | 1.5% | ₩9.89 Billion | ₩644.83 Billion | ▼ -1.1 pp |
| 2014 | 2.6% | ₩16.23 Billion | ₩620.88 Billion | — |